Immunoglobulins Market
Immunoglobulins Market Study by Intravenous, Subcutaneous, and Intramuscular Administration for Neurology, Immunology, and Hematology from 2023 to 2033
Analysis of Immunoglobulins Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Table of Content
1. Preface 1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Market 4. Market Overview 4.1. Introduction 4.1.1. Market Definition 4.1.2. Industry Evolution / Developments 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Market Analysis and Forecast, 2023–2033 4.4.1. Global Market Value (US$ Mn) Projections 4.5. Porter’s Five Force Analysis 5. Market Outlook 5.1. Disease Prevalence & Incidence Rate Globally with Key Countries 5.2. Regulatory Scenario by Region/globally 5.3. Pipeline Analysis 6. Global Market Analysis and Forecast, by Applications 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Global Market Value Forecast, by Applications, 2023–2033 6.3.1. Neurology 6.3.2. Immunology 6.3.3. Hematology 6.3.4. Others 6.4. Global Market Attractiveness by Applications 7. Global Market Analysis and Forecast, by Route of Administration 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Global Market Value Forecast, by Route of Administration, 2023–2033 7.3.1. Intravenous 7.3.2. Subcutaneous 7.3.3. Intramuscular 7.4. Global Market Attractiveness by Route of Administration 8. Global Market Analysis and Forecast, by End-user 8.1. Introduction & Definition 8.2. Key Findings / Developments 8.3. Global Market Value Forecast, by End-user, 2023–2033 8.3.1. Hospital 8.3.2. Clinic 8.3.3. Homecare 8.4. Global Market Attractiveness by End-user 9. Global Market Analysis and Forecast, by Region 9.1. Key Findings 9.2. Global Market Value Forecast, by Region 9.2.1. North America 9.2.2. Europe 9.2.3. Asia Pacific 9.2.4. Latin America 9.2.5. Middle East & Africa 9.3. Global Market Attractiveness, by Country/Region 10. North America Market Analysis and Forecast 10.1. Introduction 10.1.1. Key Findings 10.2. North America Market Value Forecast, by Applications, 2023–2033 10.2.1. Neurology 10.2.2. Immunology 10.2.3. Hematology 10.2.4. Others 10.3. North America Market Value Forecast, by Route of Administration, 2023–2033 10.3.1. Intravenous 10.3.2. Subcutaneous 10.3.3. Intramuscular 10.4. North America Market Value Forecast, by End-user, 2023–2033 10.4.1. Hospital 10.4.2. Clinic 10.4.3. Homecare 10.5. North America Market Value Forecast, by Country, 2023–2033 10.5.1. US 10.5.2. Canada 10.6. North America Market Attractiveness Analysis 10.6.1. By Applications 10.6.2. By Route of Administration 10.6.3. By End-user 10.6.4. By Country 11. Europe Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.2. Europe Market Value Forecast by Applications, 2023–2033 11.2.1. Neurology 11.2.2. Immunology 11.2.3. Hematology 11.2.4. Others 11.3. Europe Market Value Forecast, by Route of Administration, 2023–2033 11.3.1. Intravenous 11.3.2. Subcutaneous 11.3.3. Intramuscular 11.4. Europe Market Value Forecast, by End-user, 2023–2033 11.4.1. Hospital 11.4.2. Clinic 11.4.3. Homecare 11.5. Europe Market Value Forecast, by Country/Sub-region, 2023–2033 11.5.1. Germany 11.5.2. France 11.5.3. U.K. 11.5.4. Italy 11.5.5. Spain 11.5.6. Rest of Europe 11.6. Europe Market Attractiveness Analysis 11.6.1. By Applications 11.6.2. By Route of Administration 11.6.3. By End-user 11.6.4. By Country/Sub-region 12. Asia Pacific Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Asia Pacific Market Value Forecast, by Applications, 2023–2033 12.2.1. Neurology 12.2.2. Immunology 12.2.3. Hematology 12.2.4. Others 12.3. Asia Pacific Market Value Forecast, by Route of Administration, 2023–2033 12.3.1. Intravenous 12.3.2. Subcutaneous 12.3.3. Intramuscular 12.4. Asia Pacific Market Value Forecast, by End-user, 2023–2033 12.4.1. Hospital 12.4.2. Clinic 12.4.3. Homecare 12.5. Asia Pacific Market Value Forecast, by Country/Sub-region, 2023–2033 12.5.1. Japan 12.5.2. China 12.5.3. India 12.5.4. Australia & New Zealand 12.5.5. Rest of Asia Pacific 12.6. Asia Pacific Market Attractiveness Analysis 12.6.1. By Applications 12.6.2. By Route of Administration 12.6.3. By End-user 12.6.4. By Country/Sub-region 13. Latin America Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Latin America Market Value Forecast, by Applications, 2023–2033 13.2.1. Neurology 13.2.2. Immunology 13.2.3. Hematology 13.2.4. Others 13.3. Latin America Market Value Forecast, by Route of Administration, 2023–2033 13.3.1. Intravenous 13.3.2. Subcutaneous 13.3.3. Intramuscular 13.4. Latin America Market Value Forecast, by End-user, 2023–2033 13.4.1. Hospital 13.4.2. Clinic 13.4.3. Homecare 13.5. Latin America Market Value Forecast, by Country/Sub-region, 2023–2033 13.5.1. Brazil 13.5.2. Mexico 13.5.3. Rest of Latin America 13.6. Latin America Market Attractiveness Analysis 13.6.1. By Applications 13.6.2. By Route of Administration 13.6.3. By End-user 13.6.4. By Country/Sub-region 14. Middle East & Africa Market Analysis and Forecast 14.1. Introduction 14.1.1. Key Findings 14.2. Latin America Market Value Forecast, by Applications, 2023–2033 14.2.1. Neurology 14.2.2. Immunology 14.2.3. Hematology 14.2.4. Others 14.3. Latin America Market Value Forecast, by Route of Administration, 2023–2033 14.3.1. Intravenous 14.3.2. Subcutaneous 14.3.3. Intramuscular 14.4. Latin America Market Value Forecast, by End-user, 2023–2033 14.4.1. Hospital 14.4.2. Clinic 14.4.3. Homecare 14.5. Latin America Market Value Forecast, by Country/Sub-region, 2023–2033 14.5.1. GCC Countries 14.5.2. South Africa 14.5.3. Rest of Middle East & Africa 14.6. Latin America Market Attractiveness Analysis 14.6.1. By Applications 14.6.2. By Route of Administration 14.6.3. By End-user 14.6.4. By Country/Sub-region 15. Competition Landscape 15.1. Market Player – Competition Matrix (by Tier and Size of companies) 15.2. Market Share Analysis by Company (2022) 15.3. Company Profiles 15.3.1. Shire 15.3.2. CSL Behring 15.3.3. Kedrion Biopharma Inc 15.3.4. Grifols, S.A. 15.3.5. Octapharma 15.3.6. China Biologic Products Holdings, Inc 15.3.7. Biotest AG 15.3.8. Sanquin 15.3.9. LFB SA
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Forecast, by Applications, 2023–2033
Table 02: Global Market Value (US$ Mn) Forecast, by Route of Administration, 2023–2033
Table 03: Global Market Value (US$ Mn) Forecast, by End-user, 2023–2033
Table 04: Global Market Value (US$ Mn) Forecast, by Region, 2023–2033
Table 05: North America Value (US$ Mn) Forecast, by Applications, 2023–2033
Table 06: North America Value (US$ Mn) Forecast, by Route of Administration, 2023–2033
Table 07: North America Market Value (US$ Mn) Forecast, by End-user, 2023–2033
Table 08: North America Market Value (US$ Mn) Forecast, by Country, 2023–2033
Table 09: Europe Value (US$ Mn) Forecast, by Applications, 2023–2033
Table 10 Europe Value (US$ Mn) Forecast, by Route of Administration, 2023–2033
Table 11: Europe Market Value (US$ Mn) Forecast, by End-user, 2023–2033
Table 12: Europe Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2033
Table 13: Asia Pacific Value (US$ Mn) Forecast, by Applications, 2023–2033
Table 14: Asia Pacific Value (US$ Mn) Forecast, by Route of Administration, 2023–2033
Table 15: Asia Pacific Market Value (US$ Mn) Forecast, by End-user, 2023–2033
Table 16: Asia Pacific Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2033
Table 17: Latin America Value (US$ Mn) Forecast, by Applications, 2023–2033
Table 18: Latin America Value (US$ Mn) Forecast, by Route of Administration, 2023–2033
Table 19: Latin America Market Value (US$ Mn) Forecast, by End-user, 2023–2033
Table 20: Latin America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2033
Table 21: Middle East & Africa Value (US$ Mn) Forecast, by Applications, 2023–2033
Table 22: Middle East & Africa Value (US$ Mn) Forecast, by Route of Administration, 2023–2033
Table 23: Middle East & Africa Market Value (US$ Mn) Forecast, by End-user, 2023–2033
Table 24: Middle East & Africa Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Snapshot
Figure 02: Global Market Value (US$ Mn) and Distribution, by Region, 2023 and 2033
Figure 03: Global Market Snapshot, ROA
Figure 04: Global Market Snapshot, ROA
Figure 05: Global Market Value (US$ Mn) Forecast, 2023?2033
Figure 06: Global Market Value Share, by Applications (2022)
Figure 07: Global Market Value Share, by Route of Administration (2022)
Figure 08: Global Market Value Share, by End-user (2022)
Figure 09: Global Market Value Share, by Region (2022)
Figure 10: Global Market Value Share Analysis, by Applications, 2023 and 2033
Figure 11: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Neurology, 2023–2033
Figure 12: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hematology, 2023–2033
Figure 13: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2022-2033
Figure 14: Global Market Attractiveness, by Applications, 2023–2033
Figure 15: Global Market Value Share (%), by Route of Administration, 2023 and 2033
Figure 16: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Subcutaneous, 2023–2033
Figure 17: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Intramuscular, 2023–2033
Figure 18: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Intravenous, 2023–2033
Figure 19: Global Market Attractiveness, by Route of Administration, 2023–2033
Figure 20: Global Market Value Share (%), by End-user, 2023 and 2033
Figure 22: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Clinic, 2023–2033
Figure 23: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Homecare, 2023–2033
Figure 21: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital, 2023–2033
Figure 24: Global Market Attractiveness, by End-user, 2023–2033
Figure 25: Global Market Value Share Analysis, by Region 2023 and 2033
Figure 26: Global Market Attractiveness, by Region, 2023–2033
Figure 27: North America Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2023–2033
Figure 28: North America Market Value Share (%), by Applications, 2023 and 2033
Figure 29: North America Market Attractiveness, by Applications, 2023–2033
Figure 30: North America Market Value Share (%), by Route of Administration, 2023 and 2033
Figure 31: North America Market Attractiveness, by Route of Administration, 2023–2033
Figure 32: North America Market Value Share (%), by End-user, 2023 and 2033
Figure 33: North America Market Attractiveness, by End-user, 2023–2033
Figure 34: North America Market Value Share (%), by Country, 2023 and 2033
Figure 35: North America Market Attractiveness, by Country, 2023–2033
Figure 36: Europe Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2023–2033
Figure 37: Europe Market Value Share (%), by Applications, 2023 and 2033
Figure 38: Europe Market Attractiveness, by Applications, 2023–2033
Figure 39: Europe Market Value Share (%), by Route of Administration, 2023 and 2033
Figure 40: Europe Market Attractiveness, by Route of Administration, 2023–2033
Figure 41: Europe Market Value Share (%), by End-user, 2023 and 2033
Figure 42: Europe Market Attractiveness, by End-user, 2023–2033
Figure 43: Europe Market Value Share (%), by Country/Sub-region, 2023 and 2033
Figure 44: Europe Market Attractiveness, by Country/Sub-region, 2023–2033
Figure 45: Latin America Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2023–2033
Figure 46: Asia Pacific Market Value Share (%), by Applications, 2023 and 2033
Figure 47: Asia Pacific Market Attractiveness, by Applications, 2023–2033
Figure 48: Asia Pacific Market Value Share (%), by Route of Administration, 2023 and 2033
Figure 49: Asia Pacific Market Attractiveness, by Route of Administration, 2023–2033
Figure 50: Asia Pacific Market Value Share (%), by End-user, 2023 and 2033
Figure 51: Asia Pacific Market Attractiveness, by End-user, 2023–2033
Figure 52: Asia Pacific Market Value Share (%), by Country/Sub-region, 2023 and 2033
Figure 53: Asia Pacific Market Attractiveness, by Country/Sub-region, 2023–2033
Figure 54: Latin America Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2023–2033
Figure 55: Latin America Market Value Share (%), by Applications, 2023 and 2033
Figure 56: Latin America Market Attractiveness, by Applications, 2023–2033
Figure 57: Latin America Market Value Share (%), by Route of Administration, 2023 and 2033
Figure 58: Latin America Market Attractiveness, by Route of Administration, 2023–2033
Figure 59: Latin America Market Value Share (%), by End-user, 2023 and 2033
Figure 60: Latin America Market Attractiveness, by End-user, 2023–2033
Figure 61: Latin America Market Value Share (%), by Country/Sub-region, 2023 and 2033
Figure 62: Latin America Market Attractiveness, by Country/Sub-region, 2023–2033
Figure 63: Middle East & Africa Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2023–2033
Figure 64: Middle East & Africa Market Value Share (%), by Applications, 2023 and 2033
Figure 65 Middle East & Africa Market Attractiveness, by Applications, 2023–2033
Figure 66: Middle East & Africa Market Value Share (%), by Route of Administration, 2023 and 2033
Figure 67: Middle East & Africa Market Attractiveness, by Route of Administration, 2023–2033
Figure 68: Middle East & Africa Market Value Share (%), by End-user, 2023 and 2033
Figure 69: Middle East & Africa Market Attractiveness, by End-user, 2023–2033
Figure 70: Middle East & Africa Market Value Share (%), by Country/Sub-region, 2023 and 2033
Figure 71: Middle East & Africa Market Attractiveness, by Country/Sub-region, 2023–2033
Figure 72: Global Market Share Analysis, by Company (2022)
Figure 73: Research & Development Expenses (2022)
Figure 74: Breakdown of Net Sales (% Share), by Region (2022)
Figure 75: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2022
Figure 76: Breakdown of Net Sales (% Share), by Business Segment (2022)
Figure 77: Research and Development Expenses, 2014–2022
Figure 78: Breakdown of Net Sales (% Share), by Region (2022–2022)
Figure 79: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2022
Figure 80: Research and Development Expenses, 2015-2022
Figure 81: Breakdown of Net Sales (% Share), by Region (2022)
Figure 82: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2022
Figure 83: Breakdown of Net Sales (% Share), by Business Segment (2022)
Figure 84: Research and Development Expenses, 2015-2022
Figure 85: Breakdown of Net Sales (% Share), by Region (2022)
Figure 86: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2022
Figure 87: Breakdown of Net Sales (% Share), by Business Segment (2022)
Figure 88: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2022
Figure 89: Research and Development Expenses, 2015-2022
Figure 90: Breakdown of Net Sales, by Business Segment, 2022
Figure 91: Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2022
Figure 92: Research & Development Cost, 2015–2022 (US$ Mn)
Figure 93: Breakdown of Net Sales, by Business Segment, 2022
Figure 94: Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2022
Figure 95: Research & Development Cost, 2015–2022 (US$ Mn)
Figure 96: Breakdown of Net Sales, by Business Segment, 2022
Figure 97: Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2022
Figure 98: Research & Development Cost, 2015–2022 (US$ Mn)
Figure 99: Breakdown of Net Sales, by Business Segment, 2022
Figure 100: Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2022
Figure 101: Research & Development Cost, 2015–2022 (US$ Mn)
Figure 102: Breakdown of Net Sales, by Business Segment, 2022
Figure 103: Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2022
Figure 104: Research & Development Cost, 2015–2022 (US$ Mn)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Immunoglobulins Market
*Mail attachment includes 104 figures & 24 tables